You are viewing: France AI in Precision Medicine Market analysis

The France AI in Precision Medicine Market was valued at $2.26 Million in 2024 and projected to reach to $10.42 Million by 2029, representing a compound annual growth rate of 22.6%. France's AI in Precision Medicine market is poised for substantial growth, driven by increasing healthcare digitalization initiatives and government support for medical innovation.

France AI in Precision Medicine Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

France AI in Precision Medicine Market Trends and Insights

  • This represents a compound annual growth rate of 22.6%, reflecting France's commitment to advancing healthcare innovation and digital transformation within its medical sector.
  • France is positioning itself as a key player in European precision medicine adoption, driven by strong healthcare infrastructure and government support for AI-enabled diagnostics and treatment personalization. The French market benefits from significant investments in healthcare technology and a growing emphasis on data-driven clinical decision-making.
  • Between 2024 and 2029, France is expected to see accelerated integration of AI algorithms in genomics, oncology, and cardiology applications.
  • France's regulatory environment and collaborative research ecosystem are fostering partnerships between hospitals, biotech firms, and technology providers, creating a favorable landscape for precision medicine solutions. France's market trajectory underscores the country's strategic focus on leveraging artificial intelligence to improve patient outcomes and optimize healthcare delivery.
  • The forecasted growth through 2029 positions France as an increasingly important market within Europe's broader precision medicine landscape..

Key Market Statistics

  • CAGR (2024-2029) 22.6% CAGR
  • Market Size, 2024 ~USD 2.26 Million
  • Forecast, 2029 ~USD 10.42 Million
  • Country France

France AI in Precision Medicine Market Overview

Strong Market Valuation :

France's AI in Precision Medicine market reached $2.26 million in 2024, demonstrating significant investment in healthcare innovation and digital transformation across French medical institutions.

Accelerated Growth Trajectory :

With a CAGR of 22.6% through 2029, France is experiencing faster adoption of AI-driven precision medicine solutions, positioning the country as a leader in European healthcare technology advancement.

Substantial Market Expansion :

The market is projected to reach $10.42 million by 2029, representing a 360% increase over five years and reflecting France's commitment to integrating AI into personalized treatment protocols.

European Healthcare Leadership :

France is establishing itself as a key European player in precision medicine, leveraging its robust healthcare infrastructure and regulatory framework to drive AI adoption in clinical settings.

France AI in Precision Medicine Market Dynamics

  • The country's advanced healthcare system and strong research institutions are catalyzing the adoption of AI-powered diagnostic and treatment solutions.
  • French pharmaceutical companies and healthcare providers are investing heavily in precision medicine technologies to improve patient outcomes and reduce treatment costs. Looking ahead to 2029, France's market expansion will be fueled by regulatory harmonization within the EU, growing clinical validation of AI applications, and increased collaboration between academic medical centers and technology firms.
  • The integration of AI into personalized oncology, genomics, and cardiology will drive market penetration, while France's emphasis on data privacy and ethical AI implementation will establish competitive advantages in the European precision medicine landscape..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Danaher Corporation

    Analytical And Scientific Instrumentation

    Top Technologies
    • Environmental Testing
    • Gas Chromatography
    • Polymerase Chain Reaction (PCR)
    • Automated Liquid Handling Systems
    • Flow Cytometry
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Shimadzu Corporation
    • Merck KGaA

      Healthcare Analytics

      Top Technologies
      • Machine Learning
      • Natural Language Processing (NLP)
      • Blood Pressure Monitors
      • Computed Tomography (CT)
      • Magnetic Resonance Imaging (MRI)
      Top Companies
      • Oracle Corporation
      • PHILIPS HEALTHCARE
      • Siemens healthineers
      • Zensar Technologies Limited
      • EPIC SYSTEMS CORPORATION

        Key Takeaways

        • France's AI in Precision Medicine market is valued at $2.26 million in 2024 and is forecast to reach $10.42 million by 2029, representing a 22.6% CAGR.
        • France is leveraging strong healthcare infrastructure and government support to accelerate AI adoption in diagnostics, genomics, and personalized treatment planning.
        • Between 2024 and 2029, France expects significant growth in hospital-biotech partnerships and AI-enabled clinical decision support systems.
        • France's regulatory environment and collaborative research ecosystem position the country as a key European hub for precision medicine innovation.

        AI in Precision Medicine Market Report Scope

        Report Metric Details
        Base Year 2024
        Fastest Growing Segment IMAGE ANALYSIS (Tool)
        Forecast Period 2024-2029
        Growth Rate CAGR of 30.7% from 2024 to 2029
        Largest Segment SOFTWARE (Component)
        Market Size Base Year (Billions) ~USD 0.79 (2024)
        Revenue Forecast (Billions) ~USD 3.92 (2029)
        Segments Covered Application, Type, Therapeutic Area, Component, Tool, Deployment, End User, Deployment 2022-2030

        France AI in Precision Medicine Market Report Segmentation

        8 segment dimensions are covered across the global market.

        By Application

        • Clinical Development
        • De Novo Drug Design
        • Diagnostic & Screening
        • Diagnostics & Screening
        • Drug Discovery
        • Drug Discovery & Development
        • Drug Optimization
        • Drug Repurposing
        • Safety
        • Therapeutics
        • Understanding Diseases

        By Type

        • Deep Learning
        • Disease Diagnosis
        • Disease Progression, Staging & Prognosis
        • Disease Screening
        • Other Machine Learning Types
        • Post Treatment Surveillance & Follow-Up
        • Reinforcement Learning
        • Risk Assessment & Patient Stratification
        • Supervised Learning
        • Therapy Monitoring
        • Therapy Selection & Planning
        • Unsupervised Learning

        By Therapeutic Area

        • Cardiology
        • Hematology
        • Infectious Diseases
        • Neurology
        • Oncology
        • Other Therapeutic Area
        • Other Therapeutic Areas
        • Rare Disease
        • Rare Diseases

        By Component

        • Services
        • Software

        By Tool

        • Computer Vision
        • Context Aware Processing
        • Context-Aware Processing
        • Context-Aware Processing & Computing
        • Image Analysis
        • Machine Learning
        • Natural Language Processing
        • Nlp
        • Other Tools

        By Deployment

        • Cloud-Based
        • Cloud-Based Model
        • Hybrid
        • Hybrid Model
        • On-Premise
        • On-Premise Model

        By End User

        • Healthcare Providers
        • Medical Device/Equipment Companies
        • Other End Users
        • Pharmaceutical & Biotechnology Companies
        • Research Centers, Academic Institutes & Government Organizations
        • Research Centers, Academic Institutes, & Government Organizations

        By Deployment 2022-2030

        • Cloud Based
        • Cloud-Based
        • Hybrid
        • On-Premise

        FRANCE: ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY END USER, 2022–2030

        Segment202220232024202520262027202820292030CAGR (%)
        HEALTHCARE PROVIDERS7.049.2912.2616.1721.3228.0937.0148.7464.1731.8
        MEDICAL DEVICE/EQUIPMENT COMPANIES4.776.288.2710.8714.318.7924.6832.4142.5531.4
        OTHERS1.92.483.234.215.497.149.2912.0815.7130.1
        PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES5.4279.0611.715.1219.5225.1932.5141.9329.1
        RESEARCH CENTERS, ACADEMIC INSTITUTES, & GOVERNMENT ORGANIZATIONS3.083.965.076.518.3410.6813.6717.522.3828.1
        TOTAL22.2229.0237.8949.4664.5584.22109.85143.24186.7430.4

        Target Audience

        • Healthcare Technology Investors : Investment firms and venture capitalists seeking to identify high-growth opportunities in France's precision medicine sector need detailed market sizing and growth projections to allocate capital effectively.
        • Medical Device & Pharma Companies : Pharmaceutical and medical device manufacturers require France-specific market data to develop localized AI precision medicine strategies, assess competitive positioning, and plan product launches.
        • Healthcare Providers & Hospital Networks : French hospitals, clinics, and healthcare systems need market intelligence to evaluate AI precision medicine adoption, benchmark against peers, and justify technology investments to stakeholders.
        • AI & Software Solution Providers : Technology companies developing AI diagnostics and precision medicine platforms require France market insights to tailor solutions, identify customer segments, and forecast revenue potential.
        • Healthcare Policy & Regulatory Bodies : Government agencies and regulatory organizations in France need market data to inform healthcare policy, reimbursement frameworks, and digital health initiatives supporting precision medicine adoption.

        Reasons to Buy this Report

        • France-Specific Market Sizing : Obtain precise valuation data for France's AI in Precision Medicine market with verified 2024 baseline ($2.26M) and 2029 forecasts ($10.42M), enabling accurate business planning and investment decisions.
        • Competitive Landscape Intelligence : Understand France's unique market dynamics, regulatory environment, and competitive positioning within Europe to identify market entry strategies and partnership opportunities specific to French healthcare systems.
        • Growth Opportunity Assessment : Leverage France's 22.6% CAGR to identify high-potential segments in AI-driven diagnostics, treatment personalization, and genomic analysis where French healthcare providers are actively investing.
        • Strategic Investment Guidance : Make informed decisions on resource allocation and market expansion in France by understanding sector-specific growth drivers, adoption barriers, and emerging opportunities in precision medicine technology.
        • Regulatory and Market Insights : Access France-specific insights on healthcare regulations, reimbursement policies, and clinical adoption trends that directly impact AI precision medicine implementation and market viability.

        Frequently asked questions

        What is the current market size of AI in Precision Medicine in France?

        As of 2024, France's AI in Precision Medicine market is valued at $2.26 million, with expectations to grow significantly through 2029.

        What is the projected market size for France by 2029?

        France's AI in Precision Medicine market is forecast to reach $10.42 million by 2029, driven by increased adoption and investment in AI-enabled healthcare solutions.

        What is the CAGR for France's AI in Precision Medicine market?

        France's market is expected to grow at a compound annual growth rate of 22.6% between 2024 and 2029.

        Which medical specialties are driving AI adoption in France?

        Oncology, genomics, and cardiology are among the primary specialties driving AI in Precision Medicine adoption across France's healthcare system.

        What factors are supporting market growth in France?

        France's growth is supported by strong healthcare infrastructure, government backing for digital health initiatives, collaborative research partnerships, and increasing demand for personalized treatment approaches.

        RESEARCH METHODOLOGY

        The study involved significant activities to estimate the current size of the AI in precision medicine market. Exhaustive secondary research was done to collect information on the AI in precision medicine market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the AI in precision medicine market.

        Secondary Research

        This research study involved the wide use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for the companies offering AI in precision medicine solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases.

        Various secondary sources were referred to in the secondary research process to identify and collect information related to the study. These sources included annual reports, press releases, investor presentations of AI in precision medicine vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

        Primary Research

        In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the AI in precision medicine market.

        After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also undertaken to identify the segmentation types, industry trends, competitive landscape of AI in precision medicine solutions offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies.

        In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

        Breakdown of Primary Participants:

        AI in Precision Medicine Market

        Note 1: Others include sales managers, marketing managers, and product managers.

        Note 2: Tiers of companies are defined based on their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

        To know about the assumptions considered for the study, download the pdf brochure

        Market Size Estimation

        Both top-down and bottom-up approaches were used to estimate and validate the total size of the AI in precision medicine market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

        • The key players in the industry and markets have been identified through extensive secondary research.
        • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
        • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
        AI in Precision Medicine Market

        Data Triangulation

        After arriving at the overall market size using the market size estimation processes explained above, the market was split into several segments and subsegments. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

        Market Definition

        The AI in precision medicine market utilises AI technologies such as machine learning and natural language processing to analyse complicated biological and clinical data in order to provide possibly personalised healthcare solutions. It promotes applications such as drug discovery, diagnostics, predictive analytics, and tailored treatment plans by integrating genomics, proteomics, and real-world data using AI capabilities with the goal of improving patient outcomes and accelerating innovation benefits for stakeholders ranging from pharmaceutical companies and healthcare providers to researchers.

        Stakeholders

        • Transfection products manufacturing companies
        • Pharmaceutical & Biopharmaceutical Companies
        • Chemical Companies
        • Biopharmaceutical Companies
        • Contract Research Organizations (CROs)
        • Contract Development and Manufacturing Organizations (CDMOs)
        • Research Institutes and Universities 
        • Venture Capitalists & Investors
        • Government Associations

        Report Objectives

        • To define, describe, and forecast the AI in precision medicine market based on application, therapeutic area, component, tools, deployment, end user, and region.
        • To provide detailed information about the major factors (drivers, opportunities, restraints, and challenges) influencing the growth of the market
        • To analyze opportunities for stakeholders by identifying the high-growth segments of the market
        • To forecast the size of the market segments with respect to five main regions: North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America
        • To analyze subsegments of the market with respect to individual growth trends, prospects, and contributions to the overall market
        • To profile the key players and comprehensively analyze their market sizes and core competencies.
        • To track and analyze competitive developments such as acquisitions, collaborations, agreements, mergers, product launches & updates, partnerships, expansions, and other recent developments in the market globally.

        Get the Full AI in Precision Medicine Market Report

        Full forecast, segment splits, and company analysis for all AI in Precision Medicine Market.

        Need a Tailored Report?

        Customize this report to your needs

        Get 10% FREE Customization

        Customize This Report
        Fact checked
        DMCA.com Protection Status